TGFB1 and melanoma: Importantly, our data reveal that CD271 not only marks de-differentiated melanoma cells emerging, for instance, through TGFβ-mediated EMT, BRAF inhibitor-induced reprogramming16, or in response to immunotherapies17, but also is functionally involved in promoting low rates of proliferation and high metastatic capacity.